Stay updated with breaking news from Cline scientific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cline Scientific AB announces, in accordance with Nasdaq First North's regulations, that the company cannot determine with certainty that there is sufficient working capital for the Company's needs... | May 22, 2023
Today, May 22, 2023, Cline Scientific AB (the "Company") disclosed a press release with information that the Company cannot assure that it has working capital for three months. The rules of Nasdaq First
Cline Scientific, a Swedish life science company developing a novel regenerative medicine, and NecstGen, a CDMO and centre of excellence for Cell and Gene Therapy, have signed a Letter of Intent to develop and manufacture clinical batches of Cline’s cell therapy for cartilage repair, StemCART. Through this ...
With effect from May 08, 2023, the subscription rights in Cline Scientific AB will be traded on First North Growth Market. Trading will continue up until and including May 22, 2023. Instrument: Subscription
Trading in Cline Scientific AB paid subscription shares is to cease. The last trading day is December 19, 2022. Short name: CLINE BTA B ------------------------------------------------------------- ISIN
/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...